Press & Media
At GTP Bioways, we are open to media interest and inquiries regarding our business, services, and capabilities. You can use the resources on this page or reach out to our media relations team for specific inquiries. We are here to connect you with the right business leader or subject matter expert to provide the information you need.
About GTP Bioways
GTP Bioways is a CDMO, offering a unique service in developing production processes and manufacturing biotherapies, antibody-drug conjugates and nanomedicines.
With its development and production sites based in France, GTP Bioways supports biopharma companies aiming to develop innovative molecules, from R&D through to clinical trials, thanks to its GMP production development and aseptic filling capabilities.
The majority of the Toulouse-based company’s shareholders are French. The various members of the GTP Bioways group will generate a turnover of €20 million in 2022. It employs 150 staff.
Press Contact
Mrs Laurence Padiolleau
Tel: +33 7 71 18 64 73
Please do not use this phone number or email to sollicit for services or products.
Latest press releases
GTP Bioways strengthens its bioproduction capacities with the opening of a new microbial production unit
LinKinVax completes first batch production of “PanCov”, its next generation multi-variant vaccine against covid and other coronaviruses, in collaboration with GTP Bioways
GTP Bioways is opening two new biopharmaceutical production units
Press kit
Press Kit – English version
Dossier de Presse – Version Française
Featured articles
Are you looking to enhance your programme or just curious about our services?
We would love to hear from you
Please note that job applications submitted through this form will not be considered. Use the dedicated contact button on the Join Us page.
